Detalhe da pesquisa
1.
TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer.
Cancer Sci
; 112(10): 4317-4334, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314556
2.
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
N Engl J Med
; 379(7): 645-654, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30110589
3.
Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing.
Front Immunol
; 15: 1355945, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482021
4.
Corrigendum: Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing.
Front Immunol
; 15: 1389603, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482002
5.
Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.
Clin Infect Dis
; 54(11): 1642-51, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22495074
6.
The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers.
Cancers (Basel)
; 14(8)2022 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454785
7.
The TH1902 Docetaxel Peptide-Drug Conjugate Inhibits Xenografts Growth of Human SORT1-Positive Ovarian and Triple-Negative Breast Cancer Stem-like Cells.
Pharmaceutics
; 14(9)2022 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36145658
8.
Ibalizumab shows in-vitro activity against group A and group B HIV-2 clinical isolates.
AIDS
; 36(8): 1055-1060, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262531
9.
New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells.
Front Oncol
; 11: 760787, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34751242
10.
Tesamorelin improves fat quality independent of changes in fat quantity.
AIDS
; 35(9): 1395-1402, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33756511
11.
Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
AIDS
; 31(16): 2253-2259, 2017 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832410
12.
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.
J Clin Endocrinol Metab
; 95(9): 4291-304, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20554713